Whether these departments get the money will be decided later, but the Scene listened in on requests from the Department of ...

一年一度进博会，各家跨国药企“大秀肌肉”，纷纷展出自己的重磅药品。作为最火爆的赛道之一，GLP-1领域的多款产品在第七届进博会亮相，备受药企、观展者追捧。

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

由于利用GLP-1机制的药物出现，减肥药迅速发展。GLP-1是一种向大脑传达“已经吃饱”信息的激素。在这一市场领先一步的诺和诺德公司的全球总裁兼首席执行官周赋德表示，将同时开发口服型和针剂型新一代减肥药，并力争在2030年投入市场。

Regulatory watchdog South African Health Products Regulatory Authority said these types of products pose a health risk to the public.

2024年11月13日，纳微科技披露接待调研公告，公司于11月11日接待东吴证券、华商基金、中信证券、工银瑞信、华创证券等8家机构调研。公告显示，纳微科技参与本次接待的人员共3人，为董事会秘书、财务总监赵顺，证券事务代表马佳荟，证券事务专员魏骁。调研接待地点为公司会议室。据了解，纳微科技在2024年第三季度报告中披露了业绩，并与投资者就公司的经营管理、产品研发、市场拓展及团队整合等进行了交流。在G ...

Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

The South African Health Products Regulatory Authority (Sahpra) has issued a warning to the public to refrain from buying and ...

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor ...

This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...